29 related articles for article (PubMed ID: 38515748)
1. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.
Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W
Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156
[TBL] [Abstract][Full Text] [Related]
2. Immunological Characteristics of Hepatic Dendritic Cells in Patients and Mouse Model with Liver
Wang H; Li Y; Yu Q; Wang M; Ainiwaer A; Tang N; Zheng X; Duolikun A; Deng B; Li J; Shen Y; Zhang C
Trop Med Infect Dis; 2024 Apr; 9(5):. PubMed ID: 38787028
[TBL] [Abstract][Full Text] [Related]
3. Tumor Niche Network-Defined Subtypes Predict Immunotherapy Response of Esophageal Squamous Cell Cancer.
Ko KP; Zhang S; Huang Y; Kim B; Zou G; Jun S; Zhang J; Martin C; Dunbar KJ; Efe G; Rustgi AK; Zhang H; Nakagawa H; Park JI
bioRxiv; 2023 Feb; ():. PubMed ID: 36824935
[TBL] [Abstract][Full Text] [Related]
4. Integrating single-cell RNA-sequencing and bulk RNA-sequencing data to explore the role of mitophagy-related genes in prostate cancer.
Liu ZY; Huang RH
Heliyon; 2024 May; 10(9):e30766. PubMed ID: 38774081
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis.
Yao L; Jayasinghe RG; Lee BH; Bhasin SS; Pilcher W; Doxie DB; Gonzalez-Kozlova E; Dasari S; Fiala MA; Pita-Juarez Y; Strausbauch M; Kelly G; Thomas BE; Kumar SK; Cho HJ; Anderson E; Wendl MC; Dawson T; D'souza D; Oh ST; Cheloni G; Li Y; DiPersio JF; Rahman AH; Dhodapkar KM; Kim-Schulze S; Vij R; Vlachos IS; Mehr S; Hamilton M; Auclair D; Kourelis T; Avigan D; Dhodapkar MV; Gnjatic S; Bhasin MK; Ding L
Cancer Res Commun; 2022 Oct; 2(10):1255-1265. PubMed ID: 36969740
[TBL] [Abstract][Full Text] [Related]
6. Tumor niche network-defined subtypes predict immunotherapy response of esophageal squamous cell cancer.
Ko KP; Zhang S; Huang Y; Kim B; Zou G; Jun S; Zhang J; Zhao Y; Martin C; Dunbar KJ; Efe G; Rustgi AK; Nakagawa H; Zhang H; Liu Z; Park JI
iScience; 2024 May; 27(5):109795. PubMed ID: 38741711
[TBL] [Abstract][Full Text] [Related]
7. The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma.
Wang Z; Zhao Y; Wo Y; Peng Y; Hu W; Wu Z; Liu P; Shang Y; Liu C; Chen X; Huang K; Chen Y; Hong H; Li F; Sun Y
Cancer Lett; 2024 May; 593():216951. PubMed ID: 38734159
[TBL] [Abstract][Full Text] [Related]
8. Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma.
Zhou Y; Mo S; Cui H; Sun R; Zhang W; Zhuang X; Xu E; Li H; Cheng Y; Meng Y; Liu M; Yan T; Liu H; Zhang L; Yang B; Xi Y; Wang S; Cheng X; Li S; Liu Z; Zhan Q; Hu Z; Cui Y
Natl Sci Rev; 2024 May; 11(5):nwae150. PubMed ID: 38803565
[TBL] [Abstract][Full Text] [Related]
9. Identifying Key Regulatory Genes in Drug Resistance Acquisition: Modeling Pseudotime Trajectories of Breast Cancer Single-Cell Transcriptome.
Iida K; Okada M
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791962
[TBL] [Abstract][Full Text] [Related]
10. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy.
Feng DC; Zhu WZ; Wang J; Li DX; Shi X; Xiong Q; You J; Han P; Qiu S; Wei Q; Yang L
Mil Med Res; 2024 Apr; 11(1):21. PubMed ID: 38605399
[TBL] [Abstract][Full Text] [Related]
11. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing.
Zhou J; Chng WJ
Front Oncol; 2024; 14():1365330. PubMed ID: 38711849
[TBL] [Abstract][Full Text] [Related]
12. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
[TBL] [Abstract][Full Text] [Related]
13. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
Li C; Song W; Zhang J; Luo Y
Front Immunol; 2023; 14():1322147. PubMed ID: 38098487
[TBL] [Abstract][Full Text] [Related]
14. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
[TBL] [Abstract][Full Text] [Related]
15. Integrating bulk and single-cell sequencing data to construct a Scissor
Cheng M; Xiong J; Liu Q; Zhang C; Li K; Wang X; Chen S
Cancer Immunol Immunother; 2024 Apr; 73(6):97. PubMed ID: 38619620
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
